Try our beta test site
1 study found for:    CYC065
Show Display Options
Rank Status Study
1 Recruiting A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
Condition: Cancer
Intervention: Drug: CYC065

Study has passed its completion date and status has not been verified in more than two years.